Kevin Clairmont
10Patents
4h-index
24Co-inventors
56Inventor score
Filing activity: Sep 19, 1995 → Feb 24, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7041646B2 | Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists | Human Necessities | 33 | Expired |
| US6864069B2 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Human Necessities | 15 | Expired |
| US5972680A | Glucose transporter vesicle aminopeptidase | Physics | 14 | Expired |
| US8697739B2 | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7488716B2 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Human Necessities | 0 | Active |
| US7488714B2 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Human Necessities | 0 | Expired |
| US7399745B2 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Human Necessities | 0 | Expired |
| US7488715B2 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Human Necessities | 0 | Active |
| US7494978B2 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Human Necessities | 0 | Expired |
| US9789118B2 | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.